0 items USD 0.00Search
Your search for "gir asia pacific paclitaxel market manufacturers regions type application forecast 2022" gave back 1504912 results.
Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and...
Catalog:
GIR
April 2023
Price: USD 3,480.00
According to our publisher latest study, the global Albumin-bound Paclitaxel market size was valued at USD million in 2022 and is forecast to a...
Catalog:
GIR
March 2023
Price: USD 3,480.00
Nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and...
Catalog:
GIR
February 2023
Price: USD 3,480.00
A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer,...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Paclitaxel Drug-Eluting Balloon market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Paclitaxel market size was valued at USD 121 million in 2023 and is forecast to a readjusted size of USD 205.3 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Paclitaxel Injection market size was valued at USD 3482 million in 2023 and is forecast to a readjusted size of USD 7058.9 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Albumin-bound Paclitaxel market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
March 2023
Price: USD 4,480.00
The global Paclitaxel Drug-Eluting Balloon market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and...
Catalog:
GIR
February 2023
Price: USD 4,480.00
A form of the anticancer drug paclitaxel that is used alone or with other drugs to treat certain types of breast cancer, non-small cell lung cancer,...
Catalog:
GIR
February 2023
Price: USD 4,480.00
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Paclitaxel drug-eluting balloons are a type of medical device used in the treatment of peripheral artery disease (PAD). They are designed to deliver...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
The global Paclitaxel and Docetaxel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
